Novel 4-alkoxy Meriolin Congeners Potently Induce Apoptosis in Leukemia and Lymphoma Cells

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2025 Jan 8

PMID 39770138

Authors

Karina S Krings

Tobias R Wassenberg

Pablo Cea-Medina

Laura Schmitt

Ilka Lechtenberg

Tanya R Llewellyn

Nan Qin

Holger Gohlke

Sebastian Wesselborg

Thomas J J Muller

Affiliations

Soon will be listed here.

Abstract

(3-(pyrimidin-4-yl)-7-azaindoles) are synthetic hybrids of the naturally occurring alkaloids and and display a strong cytotoxic potential. We have recently shown that the novel derivative is highly cytotoxic in several lymphoma and leukemia cell lines as well as in primary patient-derived lymphoma and leukemia cells and predominantly targets cyclin-dependent kinases (CDKs). Here, we efficiently synthesized nine novel 2-aminopyridyl congeners (-), i.e., , using a one-pot borylation- coupling (MBSC) sequence, with eight of them bearing lipophilic alkoxy substituents of varying length, to systematically determine the influence of the alkoxy sidechain length on the biological activity. All the synthesized derivatives displayed a pronounced cytotoxic potential, with six compounds showing IC values in the nanomolar range. Derivatives - strongly induced apoptosis and activated caspases with rapid kinetics within 3-4 h in Jurkat leukemia and Ramos lymphoma cells. The induction of apoptosis by the most potent derivative was mediated by the intrinsic mitochondrial death pathway, as it was blocked in caspase-9 deficient and Apaf-1 knockdown Jurkat cells. However, as recently shown for derivative was able to induce apoptosis in the Jurkat cells overexpressing the antiapoptotic protein Bcl-2. Since tumor cells often inactivate the intrinsic mitochondrial apoptosis pathway (e.g., by overexpression of Bcl-2), these congeners represent promising therapeutic agents for overcoming therapeutic resistance.

References

Irie T, Sawa M . 7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors. Chem Pharm Bull (Tokyo). 2018; 66(1):29-36. DOI: 10.1248/cpb.c17-00380. View

Jarry M, Lecointre C, Malleval C, Desrues L, Schouft M, Lejoncour V . Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis. Neuro Oncol. 2014; 16(11):1484-98. PMC: 4201071. DOI: 10.1093/neuonc/nou102. View

Friesner R, Murphy R, Repasky M, Frye L, Greenwood J, Halgren T . Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006; 49(21):6177-96. DOI: 10.1021/jm051256o. View

Alexander A, Karakas C, Chen X, Carey J, Yi M, Bondy M . Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. Oncotarget. 2017; 8(9):14897-14911. PMC: 5362453. DOI: 10.18632/oncotarget.14689. View

Zhang H, Ye H, Conway B, Derian C, Addo M, Kuo G . 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3. Bioorg Med Chem Lett. 2004; 14(12):3245-50. DOI: 10.1016/j.bmcl.2004.03.090. View

Roe D, Cheatham 3rd T . PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J Chem Theory Comput. 2015; 9(7):3084-95. DOI: 10.1021/ct400341p. View

Benjamin D, Magrath I, Maguire R, Janus C, Todd H, Parsons R . Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type. J Immunol. 1982; 129(3):1336-42. View

Schmitt L, Lechtenberg I, Driessen D, Flores-Romero H, Skowron M, Sekeres M . Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2. Cell Death Discov. 2024; 10(1):125. PMC: 10924942. DOI: 10.1038/s41420-024-01901-y. View

Schneider U, Schwenk H, Bornkamm G . Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer. 1977; 19(5):621-6. DOI: 10.1002/ijc.2910190505. View

10.

Schmitt L, Hoppe J, Cea-Medina P, Bruch P, Krings K, Lechtenberg I . Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs). Cell Death Discov. 2024; 10(1):279. PMC: 11167047. DOI: 10.1038/s41420-024-02056-6. View

11.

Huang S, Li R, Connolly P, Emanuel S, Middleton S . Synthesis of 2-amino-4-(7-azaindol-3-yl)pyrimidines as cyclin dependent kinase 1 (CDK1) inhibitors. Bioorg Med Chem Lett. 2006; 16(18):4818-21. DOI: 10.1016/j.bmcl.2006.06.073. View

12.

Nicoletti I, Migliorati G, Pagliacci M, Grignani F, Riccardi C . A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991; 139(2):271-9. DOI: 10.1016/0022-1759(91)90198-o. View

13.

Chen H, Kanai M, Inoue-Yamauchi A, Tu H, Huang Y, Ren D . An interconnected hierarchical model of cell death regulation by the BCL-2 family. Nat Cell Biol. 2015; 17(10):1270-81. PMC: 4589531. DOI: 10.1038/ncb3236. View

14.

Van Opdenbosch N, Lamkanfi M . Caspases in Cell Death, Inflammation, and Disease. Immunity. 2019; 50(6):1352-1364. PMC: 6611727. DOI: 10.1016/j.immuni.2019.05.020. View

15.

Wucherer-Plietker M, Merkul E, Muller T, Esdar C, Knochel T, Heinrich T . Discovery of novel 7-azaindoles as PDK1 inhibitors. Bioorg Med Chem Lett. 2016; 26(13):3073-3080. DOI: 10.1016/j.bmcl.2016.05.005. View

16.

Johnston R, Yao K, Kaplan Z, Chelliah M, Leswing K, Seekins S . Epik: p and Protonation State Prediction through Machine Learning. J Chem Theory Comput. 2023; 19(8):2380-2388. DOI: 10.1021/acs.jctc.3c00044. View

17.

Merour J, Buron F, Ple K, Bonnet P, Routier S . The azaindole framework in the design of kinase inhibitors. Molecules. 2014; 19(12):19935-79. PMC: 6271083. DOI: 10.3390/molecules191219935. View

18.

Motati D, Amaradhi R, Ganesh T . Azaindole therapeutic agents. Bioorg Med Chem. 2020; 28(24):115830. PMC: 7736151. DOI: 10.1016/j.bmc.2020.115830. View

19.

Willis S, Chen L, Dewson G, Wei A, Naik E, Fletcher J . Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005; 19(11):1294-305. PMC: 1142553. DOI: 10.1101/gad.1304105. View

20.

Tian C, Kasavajhala K, Belfon K, Raguette L, Huang H, Migues A . ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution. J Chem Theory Comput. 2019; 16(1):528-552. DOI: 10.1021/acs.jctc.9b00591. View